Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Malaysian Health Technology Assessment (MaHTAS). Chlorthalidone for hypertensive patients
. Putrajaya: Malaysian Health Technology Assessment (MaHTAS). 2013 Authors' objectives To review evidence on the safety, efficacy/effectiveness and cost-effectiveness of Chlorthalidone to reduce
cardiovascular events compared with current practice with hydrochlorothiazide.
Authors' conclusions The studies available were of good level but limited evidence to show Chlorthalidone could reduce
cardiovascular events in hypertensive patients.
INAHTA brief and checklist INAHTA brief and checklist Indexing Status Subject indexing assigned by CRD MeSH Antihypertensive Agents; Chlorthalidone; Humans; Hypertension Language Published English Country of organisation Malaysia English summary An English language summary is available. Address for correspondence Health Technology Assessment Section, Ministry of Health Malaysia, Federal Government Administrative Centre, Level 4, Block E1, Parcel E, 62590 Putrajaya Malaysia
Tel: +603 888 312 29 Email: htamalaysia@moh.gov.my AccessionNumber 32016000316 Date abstract record published 24/02/2016 |